Recombinant Mouse CX3CL1/Fractalkine (Full Length) Protein
Recombinant Mouse CX3CL1/Fractalkine (Full Length) Protein Summary
Product Specifications
Gln25-Arg337, with a C-terminal 6-His tag
Analysis
Product Datasheets
472-FF (with carrier)
472-FF/CF (carrier free)
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
472-FF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 10 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
472-FF/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: CX3CL1/Fractalkine
Fractalkine, designated CX3CL1 and also known as neurotactin, is the only member of the CX3C, or delta, chemokine subfamily (1 ‑ 4). Unlike most other chemokines, CX3CL1 is a type I transmembrane (TM) adhesion protein (1). The mouse CX3CL1 cDNA encodes 395 amino acids (aa), including a signal sequence (aa 1 ‑ 24), a chemokine domain (aa 25 ‑ 100), a mucin stalk region (aa 101 ‑ 336), a transmembrane segment (aa 337 ‑ 357), and a cytoplasmic tail (aa 358 ‑ 395). The chemokine domain contains binding and chemotactic determinants, while the mucin stalk appears to function only as a spacer (4, 5). Mouse CX3CL1 shares 85% and 78% aa sequence identity with rat and human CX3CL1, respectively, within the chemokine domain, but lower sequence identity within other domains. CX3CL1 is up‑regulated by pro‑inflammatory stimuli, especially IFN‑ gamma and TNF‑ alpha, on cell types including macrophages, dendritic cells, endothelium, neurons, smooth muscle and epithelium lining the intestines and other tubules (1, 8, 9). The 40 kDa, 7‑TM non‑glycosylated G‑protein coupled CX3CL1 receptor, CX3CR1, is expressed by cytotoxic effector cells and cytokine producers, including type I helper and cytotoxic T cells, gamma δ T cells, CD16+ NK cells, monocytes and microglia (1, 2). The 95 ‑ 100 kDa TM CX3CL1 can be inducibly cleaved near the TM segment by ADAM10 or ADAM17 to generate a 60 ‑ 80 kDa soluble form (6, 7). TM CX3CL1 functions as an adhesion molecule, while both forms are chemoattractants for target cells expressing CX3CR1 (1, 2). During extravasation, membrane‑bound CX3CL1 traps leukocytes, then is cleaved to allow diapedesis (6). In coronary artery disease, soluble CX3CL1 and CD8+ T cell CX3CR1 are overexpressed and appear to contribute to pathogenesis (1, 10). In the brain, CX3CL1/CX3CR1 interaction protects against microglial neurotoxicity (11). CX3CL1 also contributes to wound healing by recruiting macrophages, and to bone resorption by recruiting and mediating adhesion of osteoclast precursors (12, 13).
-
Stievano, L. et al. (2004) Crit. Rev. Immunol. 24:205.
-
Umehara, H. et al. (2004) Arterioscler. Thromb. Vasc. Biol. 24:34.
-
Rossi, D.L. et al. (1998) Genomics 47:163.
-
Mizoue, L.S. et al. (2001) J. Biol. Chem. 276:33906.
-
Harrison, J.K. et al. (2001) J. Biol. Chem. 276:21632.
-
Hundhausen, C. et al. (2007) J. Immunol. 178:8064.
-
Tsou, C. et al. (2001) J. Biol. Chem. 276:44622.
-
Tarozzo, G. et al. (2003) J. Neurosci. Res. 73:81.
-
Lucas, A.D. et al. (2001) Am. J. Pathol. 158:855.
-
Damas, J.K. et al. (2005) Arterioscler. Thromb. Vasc. Biol. 25:2567.
-
Cardona, A.E. et al. (2006) Nat. Neurosci. 9:917.
-
Koizumi, K. et al. (2009) J. Immunol. 183:7825.
-
Ishida, Y. et al. (2008) J. Immunol. 180:569.
Citations for Recombinant Mouse CX3CL1/Fractalkine (Full Length) Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
14
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Astrocyte-derived MFG-E8 facilitates microglial synapse elimination in Alzheimer's disease mouse models
Authors: Sokolova, D;Ghansah, SA;Puletti, F;Georgiades, T;De Schepper, S;Zheng, Y;Crowley, G;Wu, L;Rueda-Carrasco, J;Koutsiouroumpa, A;Muckett, P;Freeman, OJ;Khakh, BS;Hong, S;
bioRxiv : the preprint server for biology
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
ER? mediates sex-specific protection in the App-NL-G-F mouse model of Alzheimer's disease
Authors: Demetriou, A;Lindqvist, B;Ali, HG;Shamekh, MM;Maioli, S;Inzunza, J;Varshney, M;Nilsson, P;Nalvarte, I;
bioRxiv : the preprint server for biology
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease
Authors: S De Scheppe, JZ Ge, G Crowley, LSS Ferreira, D Garceau, CE Toomey, D Sokolova, J Rueda-Carr, SH Shin, JS Kim, T Childs, T Lashley, JJ Burden, M Sasner, C Sala Frige, S Jung, S Hong
Nature Neuroscience, 2023-02-06;0(0):.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
An overlooked subset of Cx3cr1wt/wt microglia in the Cx3cr1CreER-Eyfp/wt mouse has a repopulation advantage over Cx3cr1CreER-Eyfp/wt microglia following microglial depletion
Authors: K Zhou, J Han, H Lund, NR Boggavarap, VM Lauschke, S Goto, H Cheng, Y Wang, A Tachi, C Xie, K Zhu, Y Sun, AM Osman, D Liang, W Han, K Gemzell-Da, C Betsholtz, XM Zhang, C Zhu, M Enge, B Joseph, RA Harris, K Blomgren
Journal of Neuroinflammation, 2022-01-21;19(1):20.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Ligand-competent fractalkine receptor is expressed on exosomes
Authors: EJ Park, PK Myint, MG Appiah, P Worawattan, J Inprasit, O Prajuabjin, ZY Soe, A Gaowa, E Kawamoto, M Shimaoka
Biochemistry and Biophysics Reports, 2021-02-02;26(0):100932.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
CX3CR1 Deficiency Attenuates DNFB-Induced Contact Hypersensitivity Through Skewed Polarization Towards M2 Phenotype in Macrophages
Authors: S Otobe, T Hisamoto, T Miyagaki, S Morimura, H Suga, M Sugaya, S Sato
Int J Mol Sci, 2020-10-07;21(19):.
Species: Mouse
Sample Types: Whole Cells
Applications: Cell Culture -
Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice
Authors: M Mizoguchi, Y Ishida, M Nosaka, A Kimura, Y Kuninaka, T Yahata, S Nanjo, S Toujima, S Minami, K Ino, N Mukaida, T Kondo
PLoS ONE, 2018-11-06;13(11):e0207085.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation
Authors: Y Zhang, L Zhao, X Wang, W Ma, A Lazere, HH Qian, J Zhang, M Abu-Asab, RN Fariss, JE Roger, WT Wong
Sci Adv, 2018-03-21;4(3):eaap8492.
Species: Mouse
Sample Types: In Vivo
-
Intramembranous processing by ?-secretase regulates reverse signaling of ephrin-B2 in migration of microglia
Authors: N Kemmerling, P Wunderlich, S Theil, B Linnartz-G, N Hersch, B Hoffmann, MT Heneka, B de Stroope, H Neumann, J Walter
Glia, 2017-04-03;0(0):.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling
PLoS ONE, 2016-11-04;11(11):e0165197.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis.
Authors: Ishida Y, Hayashi T, Goto T, Kimura A, Akimoto S, Mukaida N, Kondo T
J. Immunol., 2008-09-15;181(6):4208-18.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema.
Authors: McComb JG, Ranganathan M, Liu XH, Pilewski JM, Ray P, Watkins SC, Choi AM, Lee JS
Am. J. Pathol., 2008-09-04;173(4):949-61.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues.
Authors: Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, Savarin C, Hu T, Ransohoff RM
Blood, 2008-03-17;112(2):256-63.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Receptor-ligand binding in the cell-substrate contact zone: a quantitative analysis using CX3CR1 and CXCR1 chemokine receptors.
Authors: Lee FH, Haskell C, Charo IF, Boettiger D
Biochemistry, 2004-06-08;43(22):7179-86.
Species: Mouse
Sample Types: Whole Cells
Applications: Binding Assay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Mouse CX3CL1/Fractalkine (Full Length) Protein
There are currently no reviews for this product. Be the first to review Recombinant Mouse CX3CL1/Fractalkine (Full Length) Protein and earn rewards!
Have you used Recombinant Mouse CX3CL1/Fractalkine (Full Length) Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image